Research Coverage of Japanese Listed Companies, Shared Research Inc

Shared Research

Research Coverage of Japanese Listed Companies

Shared Research Inc

Pioneering research coverage of Japanese listed companies. Now customizable and interactive for global institutional investors. Corporate access reimagined.

Equity Bottom-Up

<ul><li>The company reported a sales decline of 11.4% YoY to JPY17.9bn, with an operating loss of JPY557mn.</li><li>Pharmaceuticals Business segment sales were JPY12.1bn, including JPY5.8bn in Domestic Pharmaceuticals and JPY4.4bn in Overseas Pharmaceuticals.</li><li>R&D expenses totaled JPY3.0bn (-6.7% YoY), representing 16.9% of sales excluding royalty income, with ongoing pipeline developments.</li></ul>

The company reported a sales decline of 11.4% YoY to JPY17.9bn, with an operating loss of JPY557mn.Pharmaceuticals Business segment sales were JPY12.1bn, including JPY5.8bn in Domestic Pharmaceuticals and JPY4.4bn in Overseas Pharmaceuticals.R&D expenses totaled JPY3.0bn (-6.7% YoY), representing 16.9% of sales excluding royalty income, with ongoing pipeline developments.

Seikagaku Corp (4548 JP): 1H FY03/26 flash update

<ul><li>The company reported a 12.9% YoY decline in sales to JPY8.7bn, with an operating loss of JPY365mn.</li><li>Pharmaceuticals Business segment sales were JPY5.9bn, including JPY3.0bn in Domestic and JPY1.9bn in Overseas Pharmaceuticals.</li><li>R&D expenses totaled JPY1.7bn (+8.6% YoY), representing 19.4% of sales excluding royalty income.</li></ul>

The company reported a 12.9% YoY decline in sales to JPY8.7bn, with an operating loss of JPY365mn.Pharmaceuticals Business segment sales were JPY5.9bn, including JPY3.0bn in Domestic and JPY1.9bn in Overseas Pharmaceuticals.R&D expenses totaled JPY1.7bn (+8.6% YoY), representing 19.4% of sales excluding royalty income.

Seikagaku Corp (4548 JP): Q1 FY03/26 flash update

<ul><li>The company reported FY03/25 sales of JPY39.4bn (+8.7% YoY), operating profit of JPY1.3bn (+207.9% YoY), and net income of JPY1.2bn (-44.5% YoY).</li><li>Revised FY03/25 forecast: sales JPY39.6bn, operating profit JPY1.8bn, recurring profit JPY2.4bn, net income JPY1.7bn, EPS JPY30.23.</li><li>FY03/26 forecast: sales JPY35.6bn (-9.6% YoY), operating loss JPY300mn, recurring profit JPY1.4bn (-30.2% YoY), net income JPY1.4bn (+11.2% YoY).</li></ul>

The company reported FY03/25 sales of JPY39.4bn (+8.7% YoY), operating profit of JPY1.3bn (+207.9% YoY), and net income of JPY1.2bn (-44.5% YoY).Revised FY03/25 forecast: sales JPY39.6bn, operating profit JPY1.8bn, recurring profit JPY2.4bn, net income JPY1.7bn, EPS JPY30.23.FY03/26 forecast: sales JPY35.6bn (-9.6% YoY), operating loss JPY300mn, recurring profit JPY1.4bn (-30.2% YoY), net income JPY1.4bn (+11.2% YoY).

Seikagaku Corp (4548 JP): Full-year FY03/25 flash update

Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

<ul>
<li>We analyzed the changes in margin trading positions of JPX stocks as of Oct 10th. The aggregated net margin trading position is USD17,836m.</li>
<li>We tabulate league tables for top/bottom net long/short of margin trading by value, net margin buy as multiple of ADT.</li>
<li>We highlight net margin buy/sell changes in IHI, SoftBank, Fast Retailing, Advantest, Mitsubishi Heavy Industries, Keyence, Nojima, Kobe Bussan, Hitachi, Kawasaki Heavy Industries, Ihi, Softbank, Fast Retailing, Advantest.</li>
</ul>


We analyzed the changes in margin trading positions of JPX stocks as of Oct 10th. The aggregated net margin trading position is USD17,836m.
We tabulate league tables for top/bottom net long/short of margin trading by value, net margin buy as multiple of ADT.
We highlight net margin buy/sell changes in IHI, SoftBank, Fast Retailing, Advantest, Mitsubishi Heavy Industries, Keyence, Nojima, Kobe Bussan, Hitachi, Kawasaki Heavy Industries, Ihi, Softbank, Fast Retailing, Advantest.


JPX Margin Trading Weekly (Oct 10th): IHI, SoftBank, Fast Retailing, Advantest

<ul>
<li>We analyzed the changes in margin trading positions of JPX stocks as of Aug 8th. The aggregated net margin trading position is USD15,664m.</li>
<li>We tabulate league tables for top/bottom net long/short of margin trading by value, net margin buy as multiple of ADT.</li>
<li>We highlight net margin buy/sell changes in Furukawa Electric, Disco, Mitsubishi Heavy Industries, SoftBank, Advantest, Tokyo Electron, Nintendo, IHI, Chugai Pharmaceutical, Toyota Motor, Furukawa Electric, Disco, Mitsubishi Heavy Industries.</li>
</ul>


We analyzed the changes in margin trading positions of JPX stocks as of Aug 8th. The aggregated net margin trading position is USD15,664m.
We tabulate league tables for top/bottom net long/short of margin trading by value, net margin buy as multiple of ADT.
We highlight net margin buy/sell changes in Furukawa Electric, Disco, Mitsubishi Heavy Industries, SoftBank, Advantest, Tokyo Electron, Nintendo, IHI, Chugai Pharmaceutical, Toyota Motor, Furukawa Electric, Disco, Mitsubishi Heavy Industries.


JPX Margin Trading Weekly (Aug 8th): Furukawa Electric, Disco, Mitsubishi Heavy Industries, SoftBank

Japan

SEIKAGAKU CORPORATION mainly manufactures complex-carbohydrate-base medicines and raw materials used for the pharmaceutical products.  The Company also manufactures and sells clinical reagents, diagnosis reagents, external medicine, medical equipment, and health food.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Seikagaku Corp (4548 JP)